What the company actually pays, and whether its own cash supports it.
Dividends view
Yield
1.24%Below 5Y avg (4.36%)
Annual Rate
HKD 0.02Paid unknown
Payout Ratio
0.0%Sustainable
Payback Period
93.0 yr
Last Ex-Dividend
Jul 21, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
9.77BHKD
1.24B · vs all stocks (USD)
Updated Sep 20, 2026
Trailing P/E
10.33x
Updated Sep 20, 2026
Revenue (TTM)
64.09BCNY
8.17B · vs all stocks (USD)
Updated Sep 20, 2026
Profit Margin
0.04%
Updated Sep 20, 2026
Beta
0.6140x
vs all stocks
Updated Sep 20, 2026
52-Week Change
0.54%
vs all stocks
Updated Sep 20, 2026
Forward Annual Dividend Yield
1.24%
vs all stocks
Updated Sep 20, 2026
Market Capitalization
9.77BHKD
1.24B · vs all stocks (USD)
Updated Sep 20, 2026
Enterprise Value
148.18BHKD
18.89B · vs all stocks (USD)
Updated Sep 20, 2026
Trailing P/E
10.33x
Updated Sep 20, 2026
Price to Sales (TTM)
0.1784x
Provider-reported. Market Capitalization ÷ Revenue (TTM) on this page gives 0.15×.Updated Sep 20, 2026
Price to Book (MRQ)
0.3669x
Updated Sep 20, 2026
Enterprise to Revenue
2.31x
Updated Sep 20, 2026
Enterprise to EBITDA
14.86x
Provider-reported. Enterprise Value ÷ EBITDA (TTM) on this page gives 48.75×.Updated Sep 20, 2026
Gross Margin
6.95%
Updated Sep 20, 2026
Profit Margin
0.04%
Updated Sep 20, 2026
Operating Margin
-2.46%
Updated Sep 20, 2026
Return on Assets (TTM)
0.72%
Updated Sep 20, 2026
Return on Equity (TTM)
0.62%
Updated Sep 20, 2026
Revenue (TTM)
64.09BCNY
8.17B · vs all stocks (USD)
Updated Sep 20, 2026
Revenue per Share (TTM)
10.03CNYUpdated Sep 20, 2026
Quarterly Revenue Growth
19.20%
Updated Sep 20, 2026
Gross Profit (TTM)
5.57BCNY
710.44M · vs all stocks (USD)
Updated Sep 20, 2026
EBITDA (TTM)
3.04BCNY
387.43M · vs all stocks (USD)
Updated Sep 20, 2026
Net Income (TTM)
25.40MCNY
3.24M · vs all stocks (USD)
Updated Sep 20, 2026
Quarterly Earnings Growth (YoY)
-22.46%
Updated Sep 20, 2026
Operating Cash Flow (TTM)
13.86BCNY
1.77B · vs all stocks (USD)
Updated Sep 20, 2026
Levered Free Cash Flow (TTM)
1.14BCNY
144.91M · vs all stocks (USD)
Updated Sep 20, 2026
Forward Annual Dividend Rate
0.0200HKDUpdated Sep 20, 2026
Forward Annual Dividend Yield
1.24%
vs all stocks
Updated Sep 20, 2026
Trailing Annual Dividend Rate
0.0200HKDUpdated Sep 20, 2026
Trailing Annual Dividend Yield
1.07%
vs all stocks
Updated Sep 20, 2026
5-Year Average Dividend Yield
4.36%
vs all stocks
Updated Sep 20, 2026
Payout Ratio
0.00%
Provider-reported. Trailing Annual Dividend Rate ÷ Diluted EPS (TTM) on this page gives 18.18%.Updated Sep 20, 2026
Minority Interest (Equity)
18.02BCNYFY2025 · Dec 31, 2025
Revenue
51.54BCNYFY2025 · Dec 31, 2025
Cost of Goods Sold
45.71BCNYFY2025 · Dec 31, 2025
Gross Profit
5.83BCNYFY2025 · Dec 31, 2025
Operating Income
3.17BCNY
473.32M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Pre-tax Income
1.51BCNYFY2025 · Dec 31, 2025
Income Tax Expense
479.75MCNYFY2025 · Dec 31, 2025
Net Income
1.03BCNYFY2025 · Dec 31, 2025
EBIT
3.76BCNYFY2025 · Dec 31, 2025
EBITDA (Income Statement)
10.76BCNYFY2025 · Dec 31, 2025
Research & Development
567.20MCNYFY2025 · Dec 31, 2025
Selling, General & Administrative
414.91MCNYFY2025 · Dec 31, 2025
Other Operating Expenses
393.62MCNYFY2025 · Dec 31, 2025
Non-operating Interest Income
89.07MCNYFY2025 · Dec 31, 2025
Non-operating Interest Expense
2.25BCNYFY2025 · Dec 31, 2025
EPS (Basic)
0.1100CNYFY2025 · Dec 31, 2025
EPS (Diluted)
0.1100CNYFY2025 · Dec 31, 2025
Basic Shares Outstanding
5.45BSharesFY2025 · Dec 31, 2025
Diluted Shares Outstanding
5.45BSharesFY2025 · Dec 31, 2025
Net Income from Continuing Operations
1.03BCNYFY2025 · Dec 31, 2025
Minority Interests (P&L)
-431.71MCNYFY2025 · Dec 31, 2025
Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025
Operating Cash Flow
3.01BCNYFY2025 · Dec 31, 2025
Free Cash Flow
-9.16BCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents (End of Period)
12.34BCNYFY2025 · Dec 31, 2025
Starting Profit (CF Statement)
1.03BCNYFY2025 · Dec 31, 2025
Other Non-cash Items
2.26BCNYFY2025 · Dec 31, 2025
Change in Accounts Receivable (CF)
-542.56MCNYFY2025 · Dec 31, 2025
Change in Other Assets/Liabilities
261.62MCNYFY2025 · Dec 31, 2025
Capital Expenditures
-12.17BCNYFY2025 · Dec 31, 2025
Purchase of Investments
-327.00MCNYFY2025 · Dec 31, 2025
Sale of Investments
344.12MCNYFY2025 · Dec 31, 2025
Other Investing Activity
1.27BCNYFY2025 · Dec 31, 2025
Net Investing Cash Flow
-10.88BCNYFY2025 · Dec 31, 2025
Long-term Debt Issuance
35.58BCNYFY2025 · Dec 31, 2025
Long-term Debt Payments
-33.35BCNYFY2025 · Dec 31, 2025
Common Dividends Paid
-2.95BCNYFY2025 · Dec 31, 2025
Other Financing Charges
2.32BCNYFY2025 · Dec 31, 2025
Net Financing Cash Flow
1.61BCNYFY2025 · Dec 31, 2025
Shares Outstanding
5.25BSharesUpdated Sep 20, 2026
Float Shares
1.57BSharesUpdated Sep 20, 2026
% Held by Insiders
6.18%
vs all stocks
Updated Sep 20, 2026
% Held by Institutions
4.66%
vs all stocks
Updated Sep 20, 2026
Total Cash (MRQ)
18.57BCNY
2.37B · vs all stocks (USD)
Updated Sep 20, 2026
Total Cash per Share (MRQ)
3.02CNYUpdated Sep 20, 2026
Total Debt (MRQ)
132.24BCNY
16.86B · vs all stocks (USD)
Updated Sep 20, 2026
Total Debt to Equity (MRQ)
2.66x
Updated Sep 20, 2026
Current Ratio (MRQ)
0.6740x
Updated Sep 20, 2026
Book Value per Share (MRQ)
5.07CNYUpdated Sep 20, 2026
Total Assets
186.03BCNY
27.76B · vs all stocks (USD)
FY2025 · Dec 31, 2025
Total Current Assets
30.65BCNYFY2025 · Dec 31, 2025
Total Liabilities
144.57BCNYFY2025 · Dec 31, 2025
Total Non-current Assets
155.39BCNYFY2025 · Dec 31, 2025
Total Non-current Liabilities
98.75BCNYFY2025 · Dec 31, 2025
Total Current Liabilities
45.82BCNYFY2025 · Dec 31, 2025
Cash
1.54BCNYFY2025 · Dec 31, 2025
Cash Equivalents
13.30BCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents
14.84BCNYFY2025 · Dec 31, 2025
Accounts Receivable
9.58BCNYFY2025 · Dec 31, 2025
Inventory
2.29BCNYFY2025 · Dec 31, 2025
Accounts Payable
5.81BCNYFY2025 · Dec 31, 2025
Short-term Debt
19.63BCNYFY2025 · Dec 31, 2025
Other Current Liabilities
588.33MCNYFY2025 · Dec 31, 2025
Long-term Debt
96.39BCNYFY2025 · Dec 31, 2025
Other Non-current Liabilities
1.03MCNYFY2025 · Dec 31, 2025
Common Stock (Book)
5.25BCNYFY2025 · Dec 31, 2025
Retained Earnings
2.64BCNYFY2025 · Dec 31, 2025
Total Shareholders' Equity
41.46BCNY
6.19B · vs all stocks (USD)
FY2025 · Dec 31, 2025
52-Week Low
1.77HKDUpdated Sep 20, 2026
52-Week High
2.30HKDUpdated Sep 20, 2026
52-Week Change
0.54%
vs all stocks
Updated Sep 20, 2026
Beta
0.6140x
vs all stocks
Updated Sep 20, 2026
50-Day MA
1.89HKDUpdated Sep 20, 2026
200-Day MA
2.00HKDUpdated Sep 20, 2026
Avg 10-Day Volume
408.05KSharesUpdated Sep 20, 2026
Avg 30-Day Volume
601.54KSharesUpdated Sep 20, 2026
Diluted EPS (TTM)
0.1100CNYUpdated Sep 20, 2026
2 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
The price sits below its 40-week average, on three profitable years and cash above profit.
Reads
Where is this company structurally exposed?
Within or Near the Altman Distress Zone
Debt is a large share of its assets, and large against its cash flow.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 0.3: distress zoneCritical
Altman Z-Score: 0.30
High earnings qualityNotable
Earnings Quality Score: 1.21
Supply Chain
Upstream position: supplies 5 industries, depends on 3Notable
Outgoing: 5.00Incoming: 3.00
Scale
Market cap is $1.24B, above the global median of $1.18BNotable
Market cap (USD): 1,244,811,881.311Global Median: 1,180,223,658.953
Revenue is $8.17B, above the global median of $548.88MNotable